Mucus accumulation in lungs
Pro Research Analysisby 
Searched over 200M research papers
Mucus Accumulation in Lungs: Causes and Mechanisms
Mucus accumulation in the lungs is a common feature in several respiratory diseases, including chronic obstructive pulmonary disease (COPD), asthma, cystic fibrosis, and infections like COVID-19. This buildup can result from increased mucus production, decreased clearance, or both, leading to airway obstruction and impaired lung function Kim1997Alvarado2022Alvarado2020+6 MORE.
Overproduction and Hypersecretion of Mucus
In many lung diseases, mucus is overproduced by goblet cells and submucosal glands. This is often triggered by inflammation, infection, or genetic factors. For example, in COVID-19, there is a marked increase in the expression of mucin genes, especially MUC5B, leading to widespread mucus plugging in the airways and alveolar spaces . Similarly, chronic bronchitis and COPD are characterized by mucus hypersecretion due to chronic inflammation and irritation, often from smoking or environmental exposures Burgel20206Ramos2014+1 MORE.
Impaired Mucociliary Clearance
Normally, mucus is cleared from the lungs by ciliary movement and coughing. In diseases like COPD, cystic fibrosis, and primary ciliary dyskinesia, this clearance mechanism is compromised. Factors such as airway wall stiffness, ciliary dysfunction, and weakened cough due to respiratory muscle problems contribute to mucus retention Alvarado2022Alvarado2020Nazir2025+1 MORE. When mucus becomes thick and sticky, it is even harder to clear, leading to further accumulation and airway plugging Kim1997Zhou-Suckow2017Panchabhai2016.
Consequences of Mucus Accumulation
Excess mucus in the lungs can cause airflow obstruction, increase the risk of respiratory infections, and worsen symptoms like cough and shortness of breath. In chronic diseases, persistent mucus accumulation is linked to reduced lung function, more frequent exacerbations, hospitalizations, and higher mortality Kim1997Burgel20206+3 MORE. Mucus plugs can also be seen in conditions such as asthma, allergic bronchopulmonary aspergillosis, and other rare lung diseases, where they may be associated with distinctive clinical and imaging findings .
Management and Treatment Strategies
Physical and Pharmacological Approaches
Managing mucus accumulation involves both physical and pharmacological methods. Physical techniques include airway clearance therapies, such as chest physiotherapy and devices that help mobilize and remove mucus Kim19976Ramos2014+1 MORE. Pharmacological treatments may include expectorants, mucolytics (to thin mucus), bronchodilators, corticosteroids, and, in some cases, antibiotics or anti-inflammatory agents Kato20226Ramos2014.
Targeted Therapies in Specific Diseases
In COVID-19, research suggests that targeting specific pathways involved in mucin gene regulation, such as EGFR and IL-1R signaling, or using corticosteroids like dexamethasone, may help reduce mucus overproduction . In COPD and other muco-obstructive diseases, restoring normal mucus concentration and improving cough efficacy with hydrating and viscosity-lowering agents are important strategies Alvarado2022Alvarado2020Zhou-Suckow2017.
Conclusion
Mucus accumulation in the lungs is a key factor in the progression and severity of many respiratory diseases. It results from a combination of increased production and impaired clearance, leading to airway obstruction and increased risk of infection. Effective management requires a combination of physical clearance techniques and targeted pharmacological therapies, tailored to the underlying disease and the specific mechanisms driving mucus buildup Kato2022Kim1997Alvarado2022+7 MORE.
Sources and full results
Most relevant research papers on this topic
Prevalence and Mechanisms of Mucus Accumulation in COVID-19 Lung Disease
SARS-CoV-2 infection is associated with a high prevalence of distal airspace mucus accumulation and increased MUC5B expression in COVID-19 lungs, suggesting potential therapeutic targets for COVID-19 lung disease.
Bronchial Mucus
Restoring mucus concentrations to normal ranges with hydrating agents and viscosity-lowering agents can effectively restore cough efficacy in muco-obstructive lung diseases.
DOI